Vous êtes sur la page 1sur 1

NURS 1566 Clinical Form 3: Clinical Medications Worksheets

(You will need to make additional copies of these forms)

Generic Trade Name Classification Dose Route Time/frequency


Name Zofran Antiemetics 4 mg=2mL IVP X1 PRN
Ondansetron
Peak Onset Duration Normal dosage range
15-30 min Rapid 4-8 hr 0.15 mg/kg
or 32 mg single dose
Why is your patient getting this medication For IV meds, compatibility with IV drips and/or solutions
For the treatment of nausea Administer undiluted.
RATE: administer over at least 30 sec and preferably over
2-5 min
Mechanism of action and indications Nursing Implications (what to focus on)
(Why med ordered) Contraindications/warnings/interactions
Blocks the effects of serotonin at 5-ht receptor sites Hypersensitivity. Use cautiously in liver impairment;
located in vagal nerve terminals and the abdominal surgery.
chemoreceptor trigger zone in the CNS. Decreases Common side effects
incidence and severity of nausea and vomiting CNS: headache, dizziness, drowsiness, fatigue, weakness.
GI: constipation, diarrhea, abdominal pain, dry mouth,
increased liver enzymes. NEURO: extrapyramidal
reactions.
Interactions with other patient drugs, OTC or herbal Lab value alterations caused by medicine
medicines (ask patient specifically) May cause transient increase in serum bilirubin, AST, and
May be affected by drugs altering the activity of liver ALT levels.
enzymes. Be sure to teach the patient the following about this
medication
Take as directed. Advise patient to notify health care
professional immediately if involuntary movement of
eyes, face, or limbs occur
Nursing Process- Assessment Assessment Evaluation
(Pre-administration assessment) Why would you hold or not give this Check after giving
Assess for nausea, vomiting, abdominal med? Improvement of nausea
distention, and bowel sounds prior to and Patient reports that nausea has and/or vomiting.
following administration. Assess patient for resolved and they are no longer
extrapyramidal effects periodically vomiting. Patient is showing signs of
extrapyramidal effects.